Ying Cheng
Naval University of Engineering
ORCID: 0000-0001-9908-597XAlso affiliated with Jilin Province Tumor Hospital, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial”.
Xiangqian Zheng, Yuan Zhang, Feng Shi, Ying Cheng, Zhuming Guo +14 more
Jordi Rodon, Yan Liang, Xinhong Wu, Qun Li, Lihua Song +23 more
Corey J. Langer, Luis Paz‐Ares, Delvys Rodríguez‐Abreu, Balázs Halmos, Marina Chiara Garassino +8 more